US2023295276A1PendingUtilityA1
Antibody for porcine reproductive and respiratory syndrome virus and uses thereof
Est. expiryMar 18, 2042(~15.6 yrs left)· nominal 20-yr term from priority
C07K 16/108C07K 16/10G01N 33/56983G01N 33/54373C07K 2317/565G01N 2333/08C07K 1/042C12N 15/63C07K 2317/33G01N 27/4145G01N 2469/10C07K 2317/92C07K 16/1018
69
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The instant disclosure discloses an antibody or antigen-binding fragment thereof binding to Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), and uses of such antibody or antigen-binding fragment thereof to create immunoassay methods or devices for PRRSV detection.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . An antibody or antigen-binding fragment thereof binding to Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), the antibody or antigen-binding fragment thereof comprising:
a heavy chain variable domain comprising a heavy chain complementarity-determining region 1 (CDR-H1) containing a sequence of SEQ ID NO: 1, a CDR-H2 containing a sequence of SEQ ID NO: 2, and a CDR-H3 containing a sequence of SEQ ID NO: 3; and a light chain variable domain comprising a light chain complementarity-determining region 1 (CDR-L1) containing a sequence of SEQ ID NO: 4, a CDR-L2 containing a sequence of Lys-Ala-Ser, and a CDR-L3 containing a sequence of SEQ ID NO: 5.
2 . The antibody or antigen-binding fragment thereof of claim 1 , wherein the heavy chain variable domain comprises a sequence of SEQ ID NO: 6.
3 . The antibody or antigen-binding fragment thereof of claim 1 , wherein the light chain variable domain comprises a sequence of SEQ ID NO: 7.
4 . An isolated nucleic acid encoding the antibody or antigen-binding fragment thereof of claim 1 , wherein the isolated nucleic acid encoding the antibody or antigen-binding fragment thereof comprises a first fragment encoding the heavy chain variable domain and a second fragment encoding the light chain variable domain.
5 . The isolated nucleic acid encoding the antibody or antigen-binding fragment thereof of claim 4 , wherein the first fragment encoding the heavy chain variable domain further comprises a sequence of SEQ ID NO: 8.
6 . The isolated nucleic acid encoding the antibody or antigen-binding fragment thereof of claim 4 , wherein the second fragment encoding the light chain variable domain further comprises a sequence of SEQ ID NO: 9.
7 . A vector comprising the isolated nucleic acid of claim 4 .
8 . A host cell comprising the vector of claim 7 .
9 . A method for producing an antibody or antigen-binding fragment thereof binding to Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), the method comprising:
(a) culturing the host cell of claim 8 under conditions suitable for expressing the antibody or antigen-binding fragment thereof; and (b) recovering the antibody or antigen-binding fragment thereof, wherein the antibody or antigen-binding fragment thereof comprises a heavy chain variable domain and a light chain variable domain.
10 . The method for producing an antibody or antigen-binding fragment thereof binding to PRRSV of claim 9 , wherein the heavy chain variable domain further comprises a sequence of SEQ ID NO: 6.
11 . The method for producing an antibody or antigen-binding fragment thereof binding to PRRSV of claim 9 , wherein the light chain variable domain further comprises a sequence of SEQ ID NO: 7.
12 . A method for detecting Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), the method comprising contacting a sample with the antibody or antigen-binding fragment thereof of claim 1 .
13 . The method of claim 12 , wherein the heavy chain variable domain further comprises a sequence of SEQ ID NO: 6.
14 . The method of claim 12 , wherein the light chain variable domain further comprises a sequence of SEQ ID NO: 7.
15 . A biological field-effect transistor (Bio-FET), comprising:
a transistor region; and a detecting region, wherein the detecting region comprises a detecting surface that is functionalized with an antibody or antigen-binding fragment thereof binding to Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), wherein the antibody or antigen-binding fragment thereof comprises:
a heavy chain variable domain comprising a heavy chain complementarity-determining region 1 (CDR-H1) containing a sequence of SEQ ID NO: 1, a CDR-H2 containing a sequence of SEQ ID NO: 2, and a CDR-H3 containing a sequence of SEQ ID NO: 3; and
a light chain variable domain comprising a light chain complementarity-determining region 1 (CDR-L1) containing a sequence of SEQ ID NO: 4, a CDR-L2 containing a sequence of Lys-Ala-Ser, and a CDR-L3 containing a sequence of SEQ ID NO: 5.
16 . The Bio-FET of claim 15 , wherein the heavy chain variable domain further comprises a sequence of SEQ ID NO: 6.
17 . The Bio-FET of claim 15 , wherein the light chain variable domain further comprises a sequence of SEQ ID NO: 7.
18 . A method for detecting Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) by using a biological field-effect transistor (Bio-FET), the method comprising:
(a) contacting a sample with an antibody or antigen-binding fragment thereof immobilized on a detecting surface of the Bio-FET, wherein the antibody or antigen-binding fragment thereof comprises:
a heavy chain variable domain comprising a heavy chain complementarity-determining region 1 (CDR-H1) containing a sequence of SEQ ID NO: 1, a CDR-H2 containing a sequence of SEQ ID NO: 2, and a CDR-H3 containing a sequence of SEQ ID NO: 3; and
a light chain variable domain comprising a CDR-L1 containing a sequence of SEQ ID NO: 4, a CDR-L2 containing a sequence of Lys-Ala-Ser, and a CDR-L3 containing a sequence of SEQ ID NO: 5,
wherein the antibody or antigen-binding fragment thereof binds to PRRSV; and
(b) analyzing an electric signal obtained from the Bio-FET.
19 . The method of claim 18 , wherein the heavy chain variable domain further comprises a sequence of SEQ ID NO: 6.
20 . The method of claim 18 , wherein the light chain variable domain further comprises a sequence of SEQ ID NO: 7.Join the waitlist — get patent alerts
Track US2023295276A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.